HCM
JAZZ icon

Harvey Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Harvey Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.68M Buy
35,320
+350
+1% +$61.2K 1.52% 18
2025
Q4 		$5.94M Sell
34,970
-2,805
-7% -$430K 1.27% 20
2025
Q3 		$4.98M Sell
37,775
-1,610
-4% -$193K 1.06% 25
2025
Q2 		$4.31M Buy
39,385
+13,980
+55% +$1.52M 1.01% 31
2025
Q1 		$3.15M Sell
25,405
-45
-0.2% -$5.87K 0.83% 38
2024
Q4 		$3.13M Buy
+25,450
New +$3M 0.74% 38

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Harvey Capital Management's JAZZ Position: Q1 2026 in Review

Harvey Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 1% in Q1 2026, buying an estimated $61.2K and bringing the position to 35,320 shares worth $6.68M. The position accounts for 1.52% of the portfolio, ranked #18.

Harvey Capital Management first reported a position in JAZZ in Q4 2024 and has held it in 6 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Harvey Capital Management held 35,320 shares of Jazz Pharmaceuticals worth $6.68M as of Q1 2026.
  • Harvey Capital Management bought 350 Jazz Pharmaceuticals shares in Q1 2026, an estimated $61.2K.
  • Jazz Pharmaceuticals made up 1.52% of Harvey Capital Management's portfolio in Q1 2026, its #18 holding.
  • Harvey Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Harvey Capital Management's 13F filing for Q1 2026, filed 11 May 2026.